Clinical Characteristics and Drug Resistance Mechanisms of Linezolid-Non-Susceptible Enterococcus in a Tertiary Hospital in Northwest China

References

• Byappanahalli MN, Nevers MB, Korajkic A, et al. Enterococci in the environment. Microbiol Mol Biol Rev. 2012;76(4):685–706. doi:10.1128/MMBR.00023-12
   PubMed Web of Science ®Google Scholar
• Long KS, Wester B. Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob Agents Chemother. 2012;56(2):603–612. doi:10.1128/AAC.05702-11
   PubMed Web of Science ®Google Scholar
• Klare I, Fleige C, Geringer U, et al. Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients. J Glob Antimicrob Resist. 2015;3(2):128–131. doi:10.1016/j.jgar.2015.02.007
   PubMed Web of Science ®Google Scholar
• Tamang MD, Moon DC, Kim SR, et al. Detection of novel oxazolidinone and phenicol resistance gene optrA in enterococcal isolates from food animals and animal carcasses. Vet Microbiol. 2017;201:252–256. doi:10.1016/j.vetmic.2017.01.035
   PubMed Web of Science ®Google Scholar
• Mendes RE, Flamm RK, Hogan PA, Ross JE, Jones RN. Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States. Antimicrob Agents Chemother. 2014;58(2):1243–1247. doi:10.1128/AAC.02112-13
   PubMed Web of Science ®Google Scholar
• Mendes RE, Hogan PA, Streit JM, Jones RN, Flamm RK. Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004–12). J Antimicrob Chemother. 2014;69(6):1582–1588. doi:10.1093/jac/dkt541
   PubMed Web of Science ®Google Scholar
• Mendes RE, Deshpande L, Streit JM, et al. ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries. J Antimicrob Chemother. 2018;73(7):1880–1887. doi:10.1093/jac/dky099
   PubMed Web of Science ®Google Scholar
• Bi R, Qin T, Fan W, Ma P, Gu B. The emerging problem of linezolid-resistant enterococci. J Glob Antimicrob Resist. 2018;13:11–19. doi:10.1016/j.jgar.2017.10.018
   PubMed Web of Science ®Google Scholar
• Kuroda M, Sekizuka T, Matsui H, et al. Complete genome sequence and characterization of linezolid-resistant Enterococcus faecalis clinical isolate KUB3006 Carrying a cfr(B)-transposon on its chromosome and optrA-Plasmid. Front Microbiol. 2018;9:2576. doi:10.3389/fmicb.2018.02576
   PubMed Web of Science ®Google Scholar
• Schwarz S, Zhang W, Du XD, et al. Mobile oxazolidinone resistance genes in gram-positive and gram-negative bacteria. Clin Microbiol Rev. 2021;34(3):e0018820. PMID: 34076490; PMCID: PMC8262807. doi:10.1128/CMR.00188-20
   PubMed Web of Science ®Google Scholar
• Brenciani A, Morroni G, Schwarz S, Giovanetti E. Oxazolidinones: mechanisms of resistance and mobile genetic elements involved. J Antimicrob Chemother. 2022;77(10):2596–2621. PMID: 35989417. doi:10.1093/jac/dkac263
   PubMed Web of Science ®Google Scholar
• Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet. 2001;358(9277):207–208. doi:10.1016/S0140-6736(01)05410-1
   PubMed Web of Science ®Google Scholar
• Mendes RE, Deshpande LM, Farrell DJ, et al. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J Antimicrob Chemother. 2010;65(11):2329–2335. doi:10.1093/jac/dkq331
   PubMed Web of Science ®Google Scholar
• Shinabarger DL, Marotti KR, Murray RW, et al. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob Agents Chemother. 1997;41(10):2132–2136. doi:10.1128/AAC.41.10.2132
   PubMed Web of Science ®Google Scholar
• Hu F, Guo Y, Yang Y, et al.; China Antimicrobial Surveillance Network (CHINET) Study Group. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-1
   PubMed Web of Science ®Google Scholar
• Cho SY, Kim HM, Chung DR, et al. Resistance mechanisms and clinical characteristics of linezolid-resistant Enterococcus faecium isolates: a single-centre study in South Korea. J Glob Antimicrob Resist. 2018;12:44–47. doi:10.1016/j.jgar.2017.09.009
   PubMed Web of Science ®Google Scholar
• Baquero F. Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist Updat. 2001;4(2):93–105. doi:10.1054/drup.2001.0196
   PubMed Web of Science ®Google Scholar
• Doern CD, Park JY, Gallegos M, Alspaugh D, Burnham CA, Richter SS. Investigation of linezolid resistance in Staphylococci and Enterococci. J Clin Microbiol. 2016;54(5):1289–1294. doi:10.1128/JCM.01929-15
   PubMed Web of Science ®Google Scholar
• Wang Y, Lv Y, Cai J, et al. A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin. J Antimicrob Chemother. 2015;70(8):2182–2190. doi:10.1093/jac/dkv116
   PubMed Web of Science ®Google Scholar
• Cai J, Wang Y, Schwarz S, et al. High detection rate of the oxazolidinone resistance gene optrA in Enterococcus faecalis isolated from a Chinese anorectal surgery ward. Int J Antimicrob Agents. 2016;48(6):757–759. doi:10.1016/j.ijantimicag.2016.08.008
   PubMed Web of Science ®Google Scholar
• Sharkey LK, Edwards TA, O’Neill AJ, Wright GD. ABC-F proteins mediate antibiotic resistance through ribosomal protection. mBio. 2016;7(2):e01975. doi:10.1128/mBio.01975-15
   PubMed Web of Science ®Google Scholar
• Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B. The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics. Antimicrob Agents Chemother. 2006;50(7):2500–2505. doi:10.1128/AAC.00131-06
   PubMed Web of Science ®Google Scholar
• Diaz L, Kiratisin P, Mendes RE, Panesso D, Singh KV, Arias CA. Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis. Antimicrob Agents Chemother. 2012;56(7):3917–3922. doi:10.1128/AAC.00419-12
   PubMed Web of Science ®Google Scholar
• Wang L, He Y, Xia Y, Wang H, Liang S. Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China. Infect Genet Evol. 2014;26:14–19. doi:10.1016/j.meegid.2014.05.001
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang Y, Schwarz S, et al. Investigation of a multiresistance gene cfr that fails to mediate resistance to phenicols and oxazolidinones in Enterococcus faecalis. J Antimicrob Chemother. 2014;69(4):892–898.
   PubMed Web of Science ®Google Scholar
• Li B, Ma CL, Yu X, et al. Investigation of mechanisms and molecular epidemiology of linezolid nonsusceptible Enterococcus faecalis isolated from a teaching hospital in China. J Microbiol Immunol Infect. 2016;49(4):595–599. doi:10.1016/j.jmii.2015.05.010
   PubMedGoogle Scholar
• Chen H, Wu W, Ni M, et al. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms. Int J Antimicrob Agents. 2013;42(4):317–321. doi:10.1016/j.ijantimicag.2013.06.008
   PubMed Web of Science ®Google Scholar